ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Machine Learning Scientist, Model-Driven Design at Generate:Biomedicines - ApplyBlast

Machine Learning Scientist, Model-Driven Design

Generate:Biomedicines

3 months ago

4.0 on Glassdoor

Somerville, Massachusetts, United States

Hybrid

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Generate:Biomedicines is seeking a machine learning scientist to lead the development of ML methods, data strategies, and closed-loop systems for protein design. The role focuses on building probabilistic models, Bayesian optimization, and LLM-enabled workflows to drive sequential decision‑making and experimental design within a collaborative, hybrid team environment.

Responsibilities

Develop new machine learning methods for lab‑in‑the‑loop protein optimization
Shape data‑generation and data‑use strategies for experimental campaigns
Design, implement, test, and maintain production‑quality ML models and data workflows

Skills

Qualifications

PhD in Machine Learning

About Generate:Biomedicines

generatebiomedicines.com

Headquarters

Somerville, Massachusetts, United States

Company Size

201-500 employees

View Profile

Generate:Biomedicines is a therapeutics company that combines machine learning, computational biology, and biological engineering to design and develop precision protein medicines and antibodies. Using generative AI and lab-driven engineering, the company builds targeted biologics and epitope-focused candidates, advancing a pipeline from discovery through clinical development. Its clinical-stage programs include GB-0895, a long‑acting anti‑TSLP antibody progressing to global Phase 3 studies, and the company has recently completed an initial public offering. Generate was incubated by Flagship Pioneering and emphasizes platform-driven discovery to accelerate novel biologic therapeutics.